Page 3 - Cronos Group News Today

Cronos Group Inc. (NASDAQ:CRON – Get Free Report)’s share price shot up 7.9% during trading on Thursday after CIBC raised their price target on the stock from $3.00 to $3.50. CIBC currently has an outperformer rating on the stock. Cronos Group traded as high as $3.14 and last traded at $3.13. 4,379,855 shares were traded […]

Shares of cannabis companies rose on Thursday afternoon after the U.S. Department of Justice unveiled a proposal to ease restrictions on marijuana, a rule if enacted would also enable more research on...

Cronos Group (NASDAQ:CRON – Free Report) had its price target raised by CIBC from $3.00 to $3.50 in a research report released on Wednesday morning, MarketBeat reports. They currently have an outperformer rating on the stock. Separately, Bank of America increased their target price on shares of Cronos Group from $2.00 to $2.50 and gave […]

The Department of Justice said it will move to reclassify marijuana after over 50 years as a Schedule 1 drug.

Without any major economic reports, earnings — especially forward guidance and management commentary — will drive the action.

Rescheduling is finally here, it seems.

(Reuters) - Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares of Cronos Group, Tilray Brands and Canopy Growth rose between...

Shares of cannabis companies surge as much as 80 percent after move to classify drug as schedule three substance.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Warren Buffett is a well-known proponent of value investing. The legendary inve...

U.S.-listed shares of Cronos Group , Tilray Brands and Canopy Growth rose between 14.9% and 67.7%, while ETF AdvisorShares Pure US Cannabis soared 24.8%.